应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
EW 爱德华兹
未开盘 07-02 16:00:00 EDT
91.23
+0.98
+1.09%
盘后
91.23
+0.00
0.00%
16:56 EDT
最高
91.36
最低
89.80
成交量
190.89万
今开
90.00
昨收
90.25
日振幅
1.73%
总市值
549.75亿
流通市值
544.27亿
总股本
6.03亿
成交额
1.73亿
换手率
0.32%
流通股本
5.97亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司
Reuters · 06-04
美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司
美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司
Reuters · 06-04
美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司
碧迪医疗(BDX)涨逾2.6% 将以42亿美元现金收购爱德华生命科学(EW)重症监护产品组
金吾资讯 · 06-04
碧迪医疗(BDX)涨逾2.6% 将以42亿美元现金收购爱德华生命科学(EW)重症监护产品组
BUZZ--美国股票走势-MarineMax、捷蓝航空公司、波士顿啤酒
Reuters · 06-03
BUZZ--美国股票走势-MarineMax、捷蓝航空公司、波士顿啤酒
碧迪医疗(BDX.US)42亿美元巨资收购爱德华生命科学(EW.US)重症监护部门 盘前涨超1%
智通财经 · 06-03
碧迪医疗(BDX.US)42亿美元巨资收购爱德华生命科学(EW.US)重症监护部门 盘前涨超1%
BUZZ-Edwards Lifesciences 上涨;将以 42 亿美元出售重症监护部门
Reuters · 06-03
BUZZ-Edwards Lifesciences 上涨;将以 42 亿美元出售重症监护部门
更新版 1-爱德华生命科学公司将以 42 亿美元的价格向 Becton Dickinson 公司出售关键产品部门
Reuters · 06-03
更新版 1-爱德华生命科学公司将以 42 亿美元的价格向 Becton Dickinson 公司出售关键产品部门
爱德华生命科学公司将以 42 亿美元的价格向 Becton Dickinson 公司出售其关键产品部门
Reuters · 06-03
爱德华生命科学公司将以 42 亿美元的价格向 Becton Dickinson 公司出售其关键产品部门
BUZZ-花旗将 Edwards Lifesciences 和 Tandem Diabetes Care 的评级上调至 "买入 "后,这两家公司股价上涨
Reuters · 05-22
BUZZ-花旗将 Edwards Lifesciences 和 Tandem Diabetes Care 的评级上调至 "买入 "后,这两家公司股价上涨
BUZZ-花旗银行将 Edwards Lifesciences 的评级上调至 "买入 "后,该公司股价上涨
Reuters · 05-22
BUZZ-花旗银行将 Edwards Lifesciences 的评级上调至 "买入 "后,该公司股价上涨
巴克莱:维持Edwards Lifesciences(EW.US)评级,由增持调整至增持评级, 目标价由100.00美元调整至101.00美元。
智通财经 · 05-07
巴克莱:维持Edwards Lifesciences(EW.US)评级,由增持调整至增持评级, 目标价由100.00美元调整至101.00美元。
爱德华生命科学2024财年第一财季实现净利润3.52亿美元,同比增加3.23%
自选股智能写手 · 04-29
爱德华生命科学2024财年第一财季实现净利润3.52亿美元,同比增加3.23%
Piper Sandler:维持Edwards Lifesciences(EW.US)评级,由中性调整至中性评级, 目标价由85.00美元调整至88.00美元。
智通财经 · 04-26
Piper Sandler:维持Edwards Lifesciences(EW.US)评级,由中性调整至中性评级, 目标价由85.00美元调整至88.00美元。
Edwards Lifesciences(EW.US):2024年Q1财报实现营收15.98亿美元
智通财经 · 04-26
Edwards Lifesciences(EW.US):2024年Q1财报实现营收15.98亿美元
爱德华生命科学公司公布截至 3 月的季度业绩 - 收益摘要
Reuters · 04-26
爱德华生命科学公司公布截至 3 月的季度业绩 - 收益摘要
Edwards Lifesciences 第一季度利润超出预期,得益于心脏设备的强劲表现
Reuters · 04-26
Edwards Lifesciences 第一季度利润超出预期,得益于心脏设备的强劲表现
未来一天的看点 - 4月25日星期四
Reuters · 04-25
未来一天的看点 - 4月25日星期四
爱德华生命科学公司 预计每股收益64美分 - 财报前瞻
Reuters · 04-24
爱德华生命科学公司 预计每股收益64美分 - 财报前瞻
媒体-EW 斯克里普斯探索出售黑人文化广播网 Bounce TV - CNBC
Reuters · 04-24
媒体-EW 斯克里普斯探索出售黑人文化广播网 Bounce TV - CNBC
BUZZ-斯蒂芬斯恢复对 UPS 和联邦快递的覆盖,分别给予 "EW "和 "OW "评级
Reuters · 04-09
BUZZ-斯蒂芬斯恢复对 UPS 和联邦快递的覆盖,分别给予 "EW "和 "OW "评级
加载更多
公司概况
公司名称:
爱德华兹
所属市场:
NYSE
上市日期:
--
主营业务:
爱德华兹生命科学公司于1999年9月10日在特拉华州注册成立。公司在结构性心脏病以及重症监护和外科监护方面处于全球领先地位。在帮助患者的热情驱使下,公司与世界领先的临床医生和研究人员合作,投资研发,以改变对结构性心脏病患者的护理,或在手术或重症监护期间需要血流动力学监测的患者的护理。
发行价格:
--
{"stockData":{"symbol":"EW","market":"US","secType":"STK","nameCN":"爱德华兹","latestPrice":91.23,"timestamp":1719950400000,"preClose":90.25,"halted":0,"volume":1908916,"hourTrading":{"tag":"盘后","latestPrice":91.23,"preClose":91.23,"latestTime":"16:56 EDT","volume":113343,"amount":10340267.89,"timestamp":1719953773324},"delay":0,"floatShares":596591595,"shares":602600000,"eps":2.320049,"marketStatus":"未开盘","marketStatusCode":0,"change":0.98,"latestTime":"07-02 16:00:00 EDT","open":90,"high":91.36,"low":89.8,"amount":173370232.7108,"amplitude":0.017285,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.320049,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1719993600000},"adr":0,"adjPreClose":90.25,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":90.25,"preClose":90.25,"latestTime":"08:01 EDT","volume":2,"amount":180.5,"timestamp":1719921688587},"postHourTrading":{"tag":"盘后","latestPrice":91.23,"preClose":91.23,"latestTime":"16:56 EDT","volume":113343,"amount":10340267.89,"timestamp":1719953773324},"volumeRatio":0.400015,"impliedVol":0.286,"impliedVolPercentile":0.4762},"requestUrl":"/m/hq/s/EW","defaultTab":"news","newsList":[{"id":"2440547009","title":"美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2440547009","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440547009?lang=zh_cn&edition=full","pubTime":"2024-06-04 15:29","pubTimestamp":1717486180,"startTime":"0","endTime":"0","summary":" 路透6月4日 - 华尔街证券分析师周二调整了对霍尼韦尔国际公司、Stericycle 和目标公司等几家美国上市公司的评级和目标价。要闻 * Brixmor Property Group Inc :高盛将该公司列入其在美上市公司信用评级名单 * 霍尼韦尔国际公司 :加拿大皇家银行将目标价从222美元下调至218美元 * 西蒙地产集团 :高盛将其股票从美国定罪名单中删除 * Stericycle Inc :加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENPH","IE00BMG7P587.USD","ZS","HON","FWONK","SRCL","GTLB","SGC","BWMN","BK4080","CMCO","EW","LU0823414478.USD","BA","S","LU1621768115.EUR","LU2286300806.USD","SPG","TER","BK4154","QCOM","HHH","TGT","GPCR","BRX","CLSK","LU1267930227.SGD","SG9999014013.SGD","HUM","BK4187","SRE","IE00BMG7P694.USD","MARA","LU1621767737.EUR","SO","FSLR","GMAB","TOL","AGIO","BK4082","LU1621767810.EUR","EQT","BK4532","BK4539","BK4155","ARWR","RIOT","BK4088"],"gpt_icon":0},{"id":"2440470047","title":"美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2440470047","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440470047?lang=zh_cn&edition=full","pubTime":"2024-06-04 15:29","pubTimestamp":1717486180,"startTime":"0","endTime":"0","summary":" 路透6月4日 - 华尔街证券分析师周二调整了对霍尼韦尔国际公司、Stericycle 和目标公司等几家美国上市公司的评级和目标价。要闻 * Brixmor Property Group Inc :高盛将该公司列入其在美上市公司信用评级名单 * 霍尼韦尔国际公司 :加拿大皇家银行将目标价从222美元下调至218美元 * 西蒙地产集团 :高盛将其股票从美国定罪名单中删除 * Stericycle Inc :加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENPH","IE00BMG7P587.USD","ZS","HON","FWONK","SRCL","GTLB","SGC","BWMN","BK4080","CMCO","EW","LU0823414478.USD","BA","S","LU1621768115.EUR","LU2286300806.USD","SPG","TER","BK4154","QCOM","HHH","TGT","GPCR","BRX","CLSK","LU1267930227.SGD","SG9999014013.SGD","HUM","BK4187","SRE","IE00BMG7P694.USD","MARA","LU1621767737.EUR","SO","FSLR","GMAB","TOL","AGIO","BK4082","LU1621767810.EUR","EQT","BK4532","BK4539","BK4155","ARWR","RIOT","BK4088"],"gpt_icon":0},{"id":"2440741306","title":"碧迪医疗(BDX)涨逾2.6% 将以42亿美元现金收购爱德华生命科学(EW)重症监护产品组","url":"https://stock-news.laohu8.com/highlight/detail?id=2440741306","media":"金吾资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440741306?lang=zh_cn&edition=full","pubTime":"2024-06-04 01:28","pubTimestamp":1717435701,"startTime":"0","endTime":"0","summary":"金吾财讯 | 碧迪医疗(BDX)股价震荡走高,高见241.635美元,涨近4%,截至发稿,仍涨2.67%,报238.17美元,成交额2.41亿美元。日前,碧迪医疗(BDX)和爱德华生命科学(EW)宣布了一项最终协议,根据该协议,碧迪医疗将以42亿美元现金收购Edwards重症监护产品组,后者是先进监测解决方案的全球领导者,从而释放新的价值创造机会并增强比对医疗的智能互联护理解决方案组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604012836958a8ced&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604012836958a8ced&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDX","LU0511384066.AUD","BK4585","LU0266013472.USD","LU1571399168.USD","LU1854103824.USD","BK4504","BK4082","EW","BK4567","LU0289739343.SGD","BK4588","LU0289961442.SGD","LU1854104046.USD"],"gpt_icon":0},{"id":"2440717498","title":"BUZZ--美国股票走势-MarineMax、捷蓝航空公司、波士顿啤酒","url":"https://stock-news.laohu8.com/highlight/detail?id=2440717498","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440717498?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:14","pubTimestamp":1717420498,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 6月3日 - 周一,纳斯达克指数和标普500指数期货以积极的态势开始了本月的交易,因为在数据密集的一周到来之前,美国国债收益率下降提振了大型成长股。美东时间9:02,道指电子盘 下跌0.03%,报38,779点。标普500指数小型股 上涨0.23%,报5,307.5点;纳斯达克100指数小型股 上涨0.55%,报18,692.75点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GME","LU2092937221.SGD","LU2106854487.HKD","BK4023","BUZZ","HZO","PARA","BK4528","IE00B19Z9Z06.USD","LU2355687059.USD","BK4585","BK4200","BK4571","SAM","LU0289960550.SGD","IE00B894F039.SGD","BK4577","LU1861215975.USD","LU1046421795.USD","LU0052756011.USD","BK4588","GPCR","SPOT","BK4158","JBLU","LU1721428933.USD","VAC","ADSK","LU1861220033.SGD","BK4141","LU0128525689.USD","BK4076","LSCC","LU0053671581.USD","LU1430594728.SGD","BA","LU1992135472.HKD","PNW","WM","BK4566","BK4142","LU1585245621.USD","LU1267930227.SGD","BK4551","LU1923621640.USD","LU1974910355.USD","LU2125910179.SGD","BK4500","LU2125910336.SGD","EW"],"gpt_icon":0},{"id":"2440528462","title":"碧迪医疗(BDX.US)42亿美元巨资收购爱德华生命科学(EW.US)重症监护部门 盘前涨超1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440528462","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440528462?lang=zh_cn&edition=full","pubTime":"2024-06-03 20:00","pubTimestamp":1717416019,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,碧迪医疗宣布,已同意以42亿美元现金收购爱德华生命科学的重症监护部门,此举旨在拓展其医疗监测产品线。此外,自2015年起担任爱德华生命科学重症监护部门副总裁的Katie Szyman,将负责领导碧迪医疗的重症监护业务。据了解,爱德华生命科学重症监护部门的产品线包括Swan Ganz肺动脉导管、微创传感器、组织血氧仪传感器以及监视器等。截至发稿,碧迪医疗盘前涨1.45%,报235.33美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1130341.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4567","EW","LU0289739343.SGD","LU1854104046.USD","LU0289961442.SGD","BK4504","BDX","LU1571399168.USD","BK4588","LU0511384066.AUD","LU1854103824.USD","BK4585","BK4082","LU0266013472.USD"],"gpt_icon":0},{"id":"2440846654","title":"BUZZ-Edwards Lifesciences 上涨;将以 42 亿美元出售重症监护部门","url":"https://stock-news.laohu8.com/highlight/detail?id=2440846654","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440846654?lang=zh_cn&edition=full","pubTime":"2024-06-03 18:57","pubTimestamp":1717412248,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 6月3日 - ** 医疗设备制造商爱德华生命科学公司 股价盘前上涨3.4%至89.80美元 ** 称已同意 (link) 将其重症监护产品部门出售给 Becton Dickinson ,全现金交易价值 42 亿美元。** 根据这项协议,公司将不再继续推进此前宣布的分拆重症监护产品部门的计划 - EW ** 预计交易将于 2024 年底完成** BDX 表示,预计将以约 10 亿美元现金和 32 亿美元新债为交易提供资金** 截至上次收盘,EW年累计上涨13.9%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","BK4504","BK4082","BUZZ","LU0289739343.SGD","LU1571399168.USD","EW","LU0289961442.SGD","BDX","LU0511384066.AUD","LU1854103824.USD","BK4588","BK4585","LU0266013472.USD","LU1854104046.USD"],"gpt_icon":0},{"id":"2440652814","title":"更新版 1-爱德华生命科学公司将以 42 亿美元的价格向 Becton Dickinson 公司出售关键产品部门","url":"https://stock-news.laohu8.com/highlight/detail?id=2440652814","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440652814?lang=zh_cn&edition=full","pubTime":"2024-06-03 18:50","pubTimestamp":1717411852,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) (添加详细信息) 路透6月3日 - 爱德华生命科学公司 周一表示,已同意将其重症监护产品部门出售给Becton Dickinson 公司 ,全现金交易价值42亿美元。 根据这项协议,总部位于加利福尼亚州的爱德华兹公司表示,它不再寻求分拆之前宣布的重症监护产品部门。 这家医疗设备制造商曾 在 4 月 (link) ,表示将在 2024 年底分拆重症监护部门,集中精力发展更大的心脏设备业务。 在满足或放弃某些成交条件的前提下,该交易预计将于2024年底完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0289739343.SGD","LU1571399168.USD","BDX","BK4082","EW","LU0289961442.SGD","LU0511384066.AUD","BK4567","LU1854104046.USD","LU0266013472.USD","BK4504","LU1854103824.USD","BK4585"],"gpt_icon":0},{"id":"2440146557","title":"爱德华生命科学公司将以 42 亿美元的价格向 Becton Dickinson 公司出售其关键产品部门","url":"https://stock-news.laohu8.com/highlight/detail?id=2440146557","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440146557?lang=zh_cn&edition=full","pubTime":"2024-06-03 18:37","pubTimestamp":1717411056,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透6月3日 - 爱德华生命科学公司(Edwards Lifesciences )周一表示,该公司已同意将其重症监护产品部门出售给Becton, Dickinson and Co 公司,该交易为全现金交易,价值42亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","BK4588","LU0289739343.SGD","LU1854104046.USD","LU0266013472.USD","LU0511384066.AUD","BK4567","LU0289961442.SGD","LU1854103824.USD","EW","BK4504","BK4585","BDX","BK4082"],"gpt_icon":0},{"id":"2437426774","title":"BUZZ-花旗将 Edwards Lifesciences 和 Tandem Diabetes Care 的评级上调至 \"买入 \"后,这两家公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2437426774","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437426774?lang=zh_cn&edition=full","pubTime":"2024-05-22 20:45","pubTimestamp":1716381913,"startTime":"0","endTime":"0","summary":" (更新) 5月22日 - ** 医疗设备制造商爱德华生命科学 股价盘前上涨1.6%至91.76美元** Tandem Diabetes Care 的股价也上涨了4.4%,达到51.50美元。** 花旗将EW和TNDM 的评级从 \"中性 \"上调至 \"买入\"** 花旗 将 EW的预测 价值从 98 美元上调至 105 美元,将TNDM 的 预测 价值从 40美元上调至 57美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EW","TNDM","BUZZ"],"gpt_icon":0},{"id":"2437250142","title":"BUZZ-花旗银行将 Edwards Lifesciences 的评级上调至 \"买入 \"后,该公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2437250142","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437250142?lang=zh_cn&edition=full","pubTime":"2024-05-22 18:24","pubTimestamp":1716373478,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 5月22日 - ** 医疗设备制造商爱德华生命科学 股价盘前上涨1.6%至91.76美元** 券商花旗研究将爱德华生命科学的评级从 \"中性 \"上调至 \"买入\",将目标价从98美元上调至105美元。** 我们认为,随着被压抑的需求和婴儿潮一代人口老龄化的共同作用下患者数量持续强劲,人们对医疗技术的兴趣普遍增加 - 花旗集团** 美国医院资本采购环境稳定,对新的输液泵和机器人技术感兴趣--花旗补充道** 截至上日收盘,股价年累计上涨 18.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","EW"],"gpt_icon":0},{"id":"2433782879","title":"巴克莱:维持Edwards Lifesciences(EW.US)评级,由增持调整至增持评级, 目标价由100.00美元调整至101.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433782879","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433782879?lang=zh_cn&edition=full","pubTime":"2024-05-07 23:25","pubTimestamp":1715095527,"startTime":"0","endTime":"0","summary":"巴克莱:维持Edwards Lifesciences(EW.US)评级,由增持调整至增持评级, 目标价由100.00美元调整至101.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072325308ae56238&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072325308ae56238&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EW"],"gpt_icon":0},{"id":"2431067325","title":"爱德华生命科学2024财年第一财季实现净利润3.52亿美元,同比增加3.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431067325","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431067325?lang=zh_cn&edition=full","pubTime":"2024-04-29 00:25","pubTimestamp":1714321550,"startTime":"0","endTime":"0","summary":"3月31日,爱德华生命科学公布财报,公告显示公司2024财年第一财季净利润为3.52亿美元,同比增加3.23%;其中营业收入为15.98亿美元,同比增加9.45%,每股基本收益为0.58美元。从资产负债表来看,爱德华生命科学总负债25.50亿美元,其中短期债务24.80百万美元,资产负债比为3.82,流动比率为3.76。机构评级:截至2024年3月31日,当前有28家机构对爱德华生命科学目标价做出预测,其中目标均价为95.91美元,其中最低目标价为72.00美元,最高目标价为105.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042900255787bb778b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042900255787bb778b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EW"],"gpt_icon":0},{"id":"2430664206","title":"Piper Sandler:维持Edwards Lifesciences(EW.US)评级,由中性调整至中性评级, 目标价由85.00美元调整至88.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2430664206","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430664206?lang=zh_cn&edition=full","pubTime":"2024-04-26 22:36","pubTimestamp":1714142195,"startTime":"0","endTime":"0","summary":"Piper Sandler:维持Edwards Lifesciences(EW.US)评级,由中性调整至中性评级, 目标价由85.00美元调整至88.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042622363887b42110&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042622363887b42110&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EW"],"gpt_icon":0},{"id":"2430216245","title":"Edwards Lifesciences(EW.US):2024年Q1财报实现营收15.98亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430216245","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430216245?lang=zh_cn&edition=full","pubTime":"2024-04-26 13:12","pubTimestamp":1714108354,"startTime":"0","endTime":"0","summary":"Edwards Lifesciences(EW.US):2024年Q1财报实现营收15.98亿美元,前值为14.6亿美元,预期值为15.7亿美元;每股收益为0.66美元,前值为0.62美元,预期值为0.64美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261327178b55abd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261327178b55abd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EW"],"gpt_icon":0},{"id":"2430262525","title":"爱德华生命科学公司公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2430262525","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430262525?lang=zh_cn&edition=full","pubTime":"2024-04-26 08:35","pubTimestamp":1714091748,"startTime":"0","endTime":"0","summary":" * 爱德华生命科学公司公布的截至 3 月份的季度调整后每股收益为 66 美分,高于去年同期的每股收益 62 美分。27位分析师对该季度的平均预期是每股收益64美分。华尔街预期为每股收益 63 美分至 66 美分。* 爱德华生命科学公司公布的本季度每股收益为 58 美分。* 公司报告的季度净收入为 3.519 亿美元。* Edwards Lifesciences Corp 的股价本季度下跌了 7.3%,今年迄今为止上涨了 16.2%。华尔街对 Edwards Lifesciences Corp 的 12 个月目标价中位数为 97.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4504","BK4082","EW","BK4567","BK4588"],"gpt_icon":0},{"id":"2430268784","title":"Edwards Lifesciences 第一季度利润超出预期,得益于心脏设备的强劲表现","url":"https://stock-news.laohu8.com/highlight/detail?id=2430268784","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430268784?lang=zh_cn&edition=full","pubTime":"2024-04-26 06:21","pubTimestamp":1714083679,"startTime":"0","endTime":"0","summary":" 路透社4月25日 - 爱德华生命科学公司周四公布,由于对其人工心脏瓣膜和其他医疗设备的需求强劲,该公司第一季度利润喜人。Edwards公司生产经导管主动脉瓣置换 设备,与雅培实验室 、波士顿科学 和美敦力 展开竞争。Edwards 第一季度的 TAVR 设备销售额增长了 6%,达到 10 亿美元,收入为 16 亿美元,超过了分析师预计的 15.7 亿美元。根据 LSEG 数据,调整后公司每股利润为 66 美分,高于分析师平均预期的 64 美分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4504","BK4082","EW","BK4567","BK4588"],"gpt_icon":0},{"id":"2430462500","title":"未来一天的看点 - 4月25日星期四","url":"https://stock-news.laohu8.com/highlight/detail?id=2430462500","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430462500?lang=zh_cn&edition=full","pubTime":"2024-04-25 02:30","pubTimestamp":1713983434,"startTime":"0","endTime":"0","summary":"美国劳工部的每周失业救济申请数据可能会显示,在截至4月20日的一周内,各州首次申请失业救济的人数增加了3000人,经季节性因素调整后为215000人。与此同时,首次领取失业救济金的人数可能从截至4月13日当周的181.2万人降至180.5万人。美国航空公司将公布第一季度财报。由于主要市场需求低迷,陶氏预计将公布第一季度收入下降的报告。烟草巨头 Altria 将公布第一季度业绩。受客户转向广告流媒体的帮助,Roku 第一季度收入预计将增长 14.52%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0642271901.SGD","KLAC","DOW","LU2023250504.SGD","LU0310800379.SGD","TSCO","LU1316542783.SGD","LU0127658192.USD","HON","CMCSA","MO","BK4112","AAL","LU2242652126.USD","JNPR","DOC","LU0114720955.EUR","WTW","HOG","LU0109392836.USD","LU1839511570.USD","AJG","LAZ","MRK","BK4516","LU1244550221.USD","BK4075","BK4576","RCL","TMUS","NDAQ","BK4515","SG9999014567.USD","COF","BMY","WST","IE00BFTCPJ56.SGD","LU0109394709.USD","SG9999014559.SGD","KDP","CAT","GILD","GOOGL","LUV","MSFT","LU0170899867.USD","INTC","LU0149725797.USD","EW","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2429140081","title":"爱德华生命科学公司 预计每股收益64美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2429140081","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429140081?lang=zh_cn&edition=full","pubTime":"2024-04-24 05:21","pubTimestamp":1713907299,"startTime":"0","endTime":"0","summary":" * 爱德华生命科学公司将于4月25日公布截至2024年3月31日的财报,预计该公司的季度收入将有所增长。* LSEG分析师对爱德华生命科学公司的平均预期为每股收益64美分。该公司 2024 年 2 月 6 日发布的截至 3 月 31 日的每股收益指导值为 0.62 美元至 0.66 美元。* 华尔街对 Edwards Lifesciences Corp 的 12 个月目标价中位数为 97.00 美元,高于其上次收盘价 87.75 美元。4月23日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EW"],"gpt_icon":0},{"id":"2429223141","title":"媒体-EW 斯克里普斯探索出售黑人文化广播网 Bounce TV - CNBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2429223141","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429223141?lang=zh_cn&edition=full","pubTime":"2024-04-24 03:56","pubTimestamp":1713902173,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 4月23日 - -- 来源链接: -- 注:路透社未核实此报道,不保证其准确性","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4567","BK4504","TV","EW","BK4100","SSP","BK4125","BK4082","BK4588"],"gpt_icon":0},{"id":"2426407119","title":"BUZZ-斯蒂芬斯恢复对 UPS 和联邦快递的覆盖,分别给予 \"EW \"和 \"OW \"评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2426407119","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426407119?lang=zh_cn&edition=full","pubTime":"2024-04-09 23:23","pubTimestamp":1712676215,"startTime":"0","endTime":"0","summary":" 4月9日 - ** 斯蒂芬斯恢复对包裹递送公司联合包裹服务公司 和联邦快递 的评级,分别为 \"等权重 \"和 \"增持\"。** UPS 股价上涨 0.3%,而 FDX 下跌 0.4** 31 家券商中有 12 家将 UPS 评为 \"买入 \"或更高评级,17 家为 \"持有\",2 家为 \"卖出\";他们的 PT 中值为 159 美元** 32 家券商中有 22 家将 FDX 评为 \"买入 \"或更高评级,8 家为 \"持有\",2 家为 \"卖出\";其预测中值为 320 美元。** 今年以来,UPS 下降 4.4%;FDX 上升 8.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDX","UPS","EW","BUZZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.edwards.com","stockEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":0.0387},{"period":"3month","weight":-0.043},{"period":"6month","weight":0.2341},{"period":"1year","weight":-0.0433},{"period":"ytd","weight":0.1836}],"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":0.0341},{"period":"3month","weight":0.0511},{"period":"6month","weight":0.1633},{"period":"1year","weight":0.2302},{"period":"ytd","weight":0.1473}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"爱德华兹生命科学公司于1999年9月10日在特拉华州注册成立。公司在结构性心脏病以及重症监护和外科监护方面处于全球领先地位。在帮助患者的热情驱使下,公司与世界领先的临床医生和研究人员合作,投资研发,以改变对结构性心脏病患者的护理,或在手术或重症监护期间需要血流动力学监测的患者的护理。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.022412},{"month":2,"riseRate":0.583333,"avgChangeRate":0.013878},{"month":3,"riseRate":0.73913,"avgChangeRate":0.023447},{"month":4,"riseRate":0.625,"avgChangeRate":0.032483},{"month":5,"riseRate":0.72,"avgChangeRate":0.032549},{"month":6,"riseRate":0.68,"avgChangeRate":0.036005},{"month":7,"riseRate":0.56,"avgChangeRate":0.015388},{"month":8,"riseRate":0.625,"avgChangeRate":0.013852},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.005417},{"month":10,"riseRate":0.458333,"avgChangeRate":-0.033863},{"month":11,"riseRate":0.666667,"avgChangeRate":0.031108},{"month":12,"riseRate":0.625,"avgChangeRate":0.044933}],"exchange":"NYSE","name":"爱德华兹","nameEN":"Edwards Lifesciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱德华兹(EW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱德华兹(EW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱德华兹,EW,爱德华兹股票,爱德华兹股票老虎,爱德华兹股票老虎国际,爱德华兹行情,爱德华兹股票行情,爱德华兹股价,爱德华兹股市,爱德华兹股票价格,爱德华兹股票交易,爱德华兹股票购买,爱德华兹股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱德华兹(EW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱德华兹(EW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}